Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.80
-0.53-6.36%
At close: -
$9.09
1.2916.54%
After Hours: Dec 26, 4:03 PM EDT
Comments
Loading...
Avalo Therapeutics (AVTX) Forecast
NewsEarningsAvalo Therapeutics (AVTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Good
Avalo Therapeutics (NASDAQ:AVTX) Stock Quotes, Forecast and News Summary
Avalo Therapeutics Stock (NASDAQ: AVTX) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Avalo Therapeutics (AVTX) stock?
You can purchase shares of Avalo Therapeutics (NASDAQ:AVTX) through any online brokerage.
Who are Avalo Therapeutics (AVTX) competitors?
Other companies in Avalo Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Genelux (NASDAQ:GNLX) and PMV Pharma (NASDAQ:PMVP).
What is the forecast, or price target, for Avalo Therapeutics (AVTX) stock?
Avalo Therapeutics has a consensus price target of $20.55.
What is the current price for Avalo Therapeutics (AVTX)?
The stock price for Avalo Therapeutics (NASDAQ: AVTX) is $9.09 last updated December 26, 2024 at 4:03 PM EST.
Does Avalo Therapeutics (AVTX) pay a dividend?
There are no upcoming dividends for Avalo Therapeutics.
When is Avalo Therapeutics (NASDAQ:AVTX) reporting earnings?
Avalo Therapeutics’s Q4 earnings are confirmed for Friday, March 28, 2025.
Is Avalo Therapeutics (AVTX) going to split?
There is no upcoming split for Avalo Therapeutics.
What sector and industry does Avalo Therapeutics (AVTX) operate in?
Avalo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.